Computational Modeling of PancreaSolve-HNX: A Theoretical Framework for Multi-Modal Nanotherapy Dynamics in Pancreatic Ductal Adenocarcinoma Treatment

Pancreatic ductal adenocarcinoma (PDAC) persists as one of the deadliest solid malignancies, characterized by a 5-year relative survival rate of only 13%, primarily due to its densely fibrotic and immunosuppressive tumor microenvironment (TME) that confers profound resistance to conventional chemotherapeutics \cite{siegel2025}. The desmoplastic stroma, accounting for 80--90% of the tumor mass, erects a substantial physical and immunological barrier, severely limiting drug penetration and efficacy \cite{collins2022}. In this study, we propose \textbf{PancreaSolve-HNX}, a rationally engineered multi-modal hybrid organic--inorganic nanoparticle system featuring a gold core integrated with sonosensitizers, a porous silica interlayer for structural stability, and a Zr\( ^{4+} \)-based metal-organic framework (MOF) shell that facilitates ultra-high loading capacities exceeding 70% w/w for gemcitabine monophosphate (GMP) \cite{ischyropoulou2023}. The nanoparticle surface is meticulously functionalized with hyaluronidase-PEG conjugates to enable targeted degradation of hyaluronan-rich extracellular matrix \cite{jakobsen2021}, iRGD peptides to promote deep tumor penetration \cite{sugahara2010}, and bispecific anti-CD47/PD-L1 nanobodies to disrupt immune checkpoint signaling and enhance antitumor immunity \cite{williams2023}.To evaluate the therapeutic potential of this design, we develop a multi-scale system of ordinary differential equations (ODEs) that extends validated frameworks for PDAC TME interactions \cite{kozminsky2020}. The model is calibrated using Bayesian inference via Hamiltonian Monte Carlo sampling in PyMC, incorporating rigorous uncertainty quantification \cite{dehond2023}. Global sensitivity analysis employing Sobol indices elucidates the dominant parameters influencing efficacy. Numerical simulations predict that a single intravenous administration of PancreaSolve-HNX, combined with three sequential focused ultrasound sessions, achieves greater than 95% ablation of viable tumor cells by day 7 through synergistic chemo-sonodynamic-photothermal mechanisms and induction of immunogenic cell death (ICD) \cite{neofytou2023}. This is followed by near-complete stromal depletion by day 10, robust systemic antitumor immune activation by day 14, and sustained tumor regression extending to 28 days. These outcomes, although contingent upon empirical validation, demonstrate strong concordance with preclinical data for constituent modalities \cite{conte2025, ischyropoulou2023} and highlight the transformative potential of integrated synergies in surmounting PDAC therapeutic barriers \cite{li2025}.Keywords: pancreatic ductal adenocarcinoma \( \cdot \) hybrid nanoparticles \( \cdot \) tumor microenvironment remodeling \( \cdot \) mathematical oncology \( \cdot \) sonodynamic therapy \( \cdot \) Bayesian inference \( \cdot \) immunogenic cell death胰腺导管腺癌（Pancreatic ductal adenocarcinoma, PDAC）仍是致死率最高的实体恶性肿瘤之一，其5年相对生存率仅为13%，这主要源于其致密纤维化且免疫抑制的肿瘤微环境（tumor microenvironment, TME），使其对常规化疗药物产生极强的耐药性cite{siegel2025}。占肿瘤质量80%~90%的促结缔组织增生基质构成了显著的物理与免疫屏障，严重限制了药物的渗透与疗效cite{collins2022}。 本研究提出**PancreaSolve-HNX**，一种经理性设计的多模态杂化有机-无机纳米颗粒系统：其核心为整合了声敏剂的金核，中间层为可维持结构稳定性的多孔二氧化硅层，外壳为基于Zr⁴⁺的金属有机框架（metal-organic framework, MOF），该外壳可实现对单磷酸吉西他滨（gemcitabine monophosphate, GMP）超过70%重量比的超高载药量cite{ischyropoulou2023}。纳米颗粒表面经过精细功能化修饰：偶联透明质酸酶-聚乙二醇（hyaluronidase-PEG）以靶向降解富含透明质酸的细胞外基质cite{jakobsen2021}，修饰iRGD肽以促进肿瘤深部渗透cite{sugahara2010}，并偶联双特异性抗CD47/PD-L1纳米抗体以阻断免疫检查点信号通路、增强抗肿瘤免疫cite{williams2023}。 为评估该设计的治疗潜力，本研究构建了多尺度常微分方程（ordinary differential equations, ODE）系统，该系统扩展了已验证的PDAC-TME相互作用模型框架cite{kozminsky2020}。模型通过PyMC软件中的哈密顿蒙特卡洛采样进行贝叶斯推断完成校准，并纳入了严格的不确定性量化cite{dehond2023}。采用Sobol指数的全局敏感性分析明确了影响治疗效果的关键参数。数值模拟结果显示：单次静脉给予PancreaSolve-HNX联合三次连续聚焦超声治疗，可通过协同化疗-声动力-光热机制以及诱导免疫原性细胞死亡（immunogenic cell death, ICD），在第7天时实现超过95%的活肿瘤细胞消融cite{neofytou2023}；第10天时可实现基质近乎完全清除，第14天时触发强效的全身性抗肿瘤免疫激活，最终实现持续至第28天的肿瘤持续消退。尽管上述结果尚需实验验证，但它们与各组成治疗模式的临床前数据高度吻合cite{conte2025, ischyropoulou2023}，同时凸显了整合协同疗法在克服PDAC治疗障碍方面的转化潜力cite{li2025}。 关键词：胰腺导管腺癌 · 杂化纳米颗粒 · 肿瘤微环境重塑 · 数学肿瘤学 · 声动力疗法 · 贝叶斯推断 · 免疫原性细胞死亡